简单的语言摘要:用于吸入物过敏的免疫疗法
Richard K Gurgel1, Fuad M Baroody2, Cecelia C Damask3
1University of Utah, Salt Lake City, Utah, USA.
概括
这篇简单的摘要解释了对5岁以上吸入剂过敏患者的过敏原免疫疗法. 它基于2024年免疫治疗临床实践指南.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 患者教育 患者教育
背景情况:
- 吸入剂过敏会影响许多患者,导致显著的症状.
- 过敏原免疫疗法是对过敏性疾病的治疗选择.
研究的目的:
- 为提供对过敏原免疫疗法的简单语言解释.
- 为患者,家属和护理人员提供有关免疫疗法选择的信息.
- 为了支持对2024年临床实践指南的理解:吸入剂过敏的免疫疗法.
主要方法:
- 来自"临床实践指南:吸入物过敏的免疫疗法"的综合信息.
- 为患者,家人和护理人员理解量身定制的内容.
- 专注于5岁及以上的患有吸入物过敏症状的患者.
主要成果:
- 摘要阐明了过敏原免疫治疗的概念和应用.
- 它强调免疫疗法作为吸入剂过敏的潜在治疗方法.
- 它作为详细的临床指南的患者友好的伴侣.
结论:
- 过敏原免疫疗法是吸入过敏的可行治疗方法.
- 这份摘要使患者及其家人能够做出明智的决定.
- 该指南为过敏治疗的最佳实践提供了基础.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
297
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
247
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
247
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Inhaled Medications
261
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
261
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


